Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
Katerina Naydenova, Kyle Muir, Long-Fei Wu, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 7
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger, Carina Stiller, Jana Schmitzová, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 740-746
Open Access | Times Cited: 613
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 411
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimır Majerčiak, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 222
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 103
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase
Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Structural basis for substrate selection by the SARS-CoV-2 replicase
Brandon Malone, Jason K. Perry, Paul Dominic B. Olinares, et al.
Nature (2023) Vol. 614, Iss. 7949, pp. 781-787
Open Access | Times Cited: 47
A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2
Xiaorui Su, Lun Hu, Zhu‐Hong You, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 70
Structure and function of SARS-CoV-2 polymerase
Hauke S. Hillen
Current Opinion in Virology (2021) Vol. 48, pp. 82-90
Open Access | Times Cited: 66
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review
Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3006-3016
Open Access | Times Cited: 62
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
Xuanting Wang, Carolina Q. Sacramento, Steffen Jockusch, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 59
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase
Federico Munafò, Elisa Donati, Nicoletta Brindani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
Arpana Parihar, Zannatul Ferdous Sonia, Farjana Akter, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105468-105468
Open Access | Times Cited: 53
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
Arun K. Ghosh, Jennifer L. Mishevich, Andrew D. Mesecar, et al.
ChemMedChem (2022) Vol. 17, Iss. 22
Open Access | Times Cited: 44
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Luis Menéndez‐Arias
Viruses (2022) Vol. 14, Iss. 4, pp. 841-841
Open Access | Times Cited: 43
CryoREAD: de novo structure modeling for nucleic acids in cryo-EM maps using deep learning
Xiao Wang, Genki Terashi, Daisuke Kihara
Nature Methods (2023) Vol. 20, Iss. 11, pp. 1739-1747
Open Access | Times Cited: 29
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
Coronaviral RNA-methyltransferases: function, structure and inhibition
Radim Nencka, Jan Šilhán, Martin Klíma, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. 2, pp. 635-650
Open Access | Times Cited: 55
Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma
Inas A. Abdallah, Sherin F. Hammad, Alaa Bedair, et al.
Journal of Chromatography B (2021) Vol. 1189, pp. 123087-123087
Open Access | Times Cited: 48
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain
Bing Wang, Dmitri Svetlov, Irina Artsimovitch
Nucleic Acids Research (2021) Vol. 49, Iss. 15, pp. 8822-8835
Open Access | Times Cited: 43
Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: Strategies, benefits, and challenges
Zhonglei Wang, Liyan Yang
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1373-1390
Closed Access | Times Cited: 43
Efficient graphene oxide coating improves cryo-EM sample preparation and data collection from tilted grids
Avinash B. Patel, Daniel B. Toso, Audrey Litvak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
In silico evaluation of food‐derived carotenoids against SARS‐CoV ‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID ‐19
Somdutt Mujwar, Lei Sun, Özkan Fidan
Journal of Food Biochemistry (2022) Vol. 46, Iss. 9
Open Access | Times Cited: 37
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108121-108121
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top